Human Genome Epidemiology Literature Finder
|
Records 1 - 3 (of 3 Records) |
| Query Trace: Neoplasms and CHST3[original query] |
|---|
| Genome-wide analysis identifies 16q deletion associated with survival, molecular subtypes, mRNA expression, and germline haplotypes in breast cancer patients. Genes, chromosomes & cancer 2008 Aug 47 (8): 680-96. Nordgard Silje H, Johansen Fredrik E, Alnaes Grethe I G, Bucher Elmar, Syvänen Ann-Christine, Naume Bjørn, Børresen-Dale Anne-Lise, Kristensen Vessela |
| A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platform. The pharmacogenomics journal 2009 12 10 (3): 191-9. Deeken J F, Cormier T, Price D K, Sissung T M, Steinberg S M, Tran K, Liewehr D J, Dahut W L, Miao X, Figg W |
| Pharmacogenomic characterization of gemcitabine response--a framework for data integration to enable personalized medicine. Pharmacogenetics and genomics 2014 Feb 24 (2): 81-93. Harris Michael, Bhuvaneshwar Krithika, Natarajan Thanemozhi, Sheahan Laura, Wang Difei, Tadesse Mahlet G, Shoulson Ira, Filice Ross, Steadman Kenneth, Pishvaian Michael J, Madhavan Subha, Deeken Jo |
- Page last reviewed:Feb 1, 2024
- Content source:

